Literature DB >> 18154359

The histamine N-methyltransferase T105I polymorphism affects active site structure and dynamics.

Karen Rutherford1, W W Parson, Valerie Daggett.   

Abstract

Histamine N-methyltransferase (HNMT) is the primary enzyme responsible for inactivating histamine in the mammalian brain. The human HNMT gene contains a common threonine-isoleucine polymorphism at residue 105, distal from the active site. The 105I variant has decreased activity and lower protein levels than the 105T protein. Crystal structures of both variants have been determined but reveal little regarding how the T105I polymorphism affects activity. We performed molecular dynamics simulations for both 105T and 105I at 37 degrees C to explore the structural and dynamic consequences of the polymorphism. The simulations indicate that replacing Thr with the larger Ile residue leads to greater burial of residue 105 and heightened intramolecular interactions between residue 105 and residues within helix alpha3 and strand beta3. This altered, tighter packing is translated to the active site, resulting in the reorientation of several cosubstrate-binding residues. The simulations also show that the hydrophobic histamine-binding domain in both proteins undergoes a large-scale breathing motion that exposes key catalytic residues and lowers the hydrophobicity of the substrate-binding site.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18154359      PMCID: PMC2905460          DOI: 10.1021/bi701737f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

Review 1.  Interactions between histaminergic and cholinergic systems in learning and memory.

Authors:  L Bacciottini; M B Passani; P F Mannaioni; P Blandina
Journal:  Behav Brain Res       Date:  2001-10-15       Impact factor: 3.332

2.  Lack of association of histamine-N-methyltransferase (HNMT) polymorphisms with asthma in the Indian population.

Authors:  Shilpy Sharma; Deepti Mann; Tej Pratap Singh; Balaram Ghosh
Journal:  J Hum Genet       Date:  2005-10-05       Impact factor: 3.172

3.  Histamine N-methyltransferase pharmacogenetics: association of a common functional polymorphism with asthma.

Authors:  L Yan; R E Galinsky; J A Bernstein; S B Liggett; R M Weinshilboum
Journal:  Pharmacogenetics       Date:  2000-04

4.  Regulation of gastric acid secretion.

Authors:  M L Schubert
Journal:  Curr Opin Gastroenterol       Date:  1999-11       Impact factor: 3.287

5.  Pharmacogenetics of N-methylation: heritability of human erythrocyte histamine N-methyltransferase activity.

Authors:  M C Scott; J A Van Loon; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  1988-03       Impact factor: 6.875

6.  Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons.

Authors:  J R Horton; K Sawada; M Nishibori; X Zhang; X Cheng
Journal:  Structure       Date:  2001-09       Impact factor: 5.006

7.  Single nucleotide polymorphisms and haplotypes of histamine N-methyltransferase in patients with gastric ulcer.

Authors:  G-L Chen; B Zhu; W-P Nie; Z-H Xu; Z-R Tan; G Zhou; J Liu; W Wang; H-H Zhou
Journal:  Inflamm Res       Date:  2004-09       Impact factor: 4.575

8.  No association of histamine- N-methyltransferase polymorphism with asthma or bronchial hyperresponsiveness in two German pediatric populations.

Authors:  Philipp Deindl; Silvija Peri-Jerkan; Klaus Deichmann; Bodo Niggemann; Susanne Lau; Christine Sommerfeld; Claudia Sengler; Sebastian Müller; Ulrich Wahn; Renate Nickel; Andrea Heinzmann
Journal:  Pediatr Allergy Immunol       Date:  2005-02       Impact factor: 6.377

9.  Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes.

Authors:  A J Shield; B A Thomae; B W Eckloff; E D Wieben; R M Weinshilboum
Journal:  Mol Psychiatry       Date:  2004-02       Impact factor: 15.992

10.  Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation.

Authors:  Julie E Goodman; Laran T Jensen; Ping He; James D Yager
Journal:  Pharmacogenetics       Date:  2002-10
View more
  8 in total

1.  Polymorphisms and disease: hotspots of inactivation in methyltransferases.

Authors:  Karen Rutherford; Valerie Daggett
Journal:  Trends Biochem Sci       Date:  2010-04-09       Impact factor: 13.807

2.  Dynameomics: a comprehensive database of protein dynamics.

Authors:  Marc W van der Kamp; R Dustin Schaeffer; Amanda L Jonsson; Alexander D Scouras; Andrew M Simms; Rudesh D Toofanny; Noah C Benson; Peter C Anderson; Eric D Merkley; Steven Rysavy; Dennis Bromley; David A C Beck; Valerie Daggett
Journal:  Structure       Date:  2010-03-14       Impact factor: 5.006

3.  Histamine N-methyltransferase Thr105Ile is not associated with Parkinson's disease or essential tremor.

Authors:  Brett H Keeling; Carles Vilariño-Güell; Alexandra I Soto-Ortolaza; Owen A Ross; Ryan J Uitti; Alex Rajput; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2009-09-20       Impact factor: 4.891

4.  Ligands in PSI structures.

Authors:  Abhinav Kumar; Hsiu Ju Chiu; Herbert L Axelrod; Andrew Morse; Marc André Elsliger; Ian A Wilson; Ashley Deacon
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-06

5.  The R46Q, R131Q and R154H polymorphs of human DNA glycosylase/beta-lyase hOgg1 severely distort the active site and DNA recognition site but do not cause unfolding.

Authors:  Peter C Anderson; Valerie Daggett
Journal:  J Am Chem Soc       Date:  2009-07-15       Impact factor: 15.419

6.  Impact of genetic variation on three dimensional structure and function of proteins.

Authors:  Roshni Bhattacharya; Peter W Rose; Stephen K Burley; Andreas Prlić
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

7.  The diamine oxidase gene is associated with hypersensitivity response to non-steroidal anti-inflammatory drugs.

Authors:  José A G Agúndez; Pedro Ayuso; José A Cornejo-García; Miguel Blanca; María J Torres; Inmaculada Doña; María Salas; Natalia Blanca-López; Gabriela Canto; Carmen Rondon; Paloma Campo; José J Laguna; Javier Fernández; Carmen Martínez; Elena García-Martín
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

8.  Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors.

Authors:  E E J Kasteel; K Darney; N I Kramer; J L C M Dorne; L S Lautz
Journal:  Arch Toxicol       Date:  2020-05-15       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.